Jazz Pharmaceuticals’ Sunosi Gets EU Marketing Authorization for Excessive Daytime Sleepiness in Narcolepsy or Obstructive Sleep Apnea
The European Commission has approved Jazz Pharmaceuticals plc’s Sunosi (solriamfetol) to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adults with narcolepsy (with or without cataplexy) or...
Read More